EKOS PE ACCEL
DEAD

Serial Number

87265335

Owner

EKOS CORPORATION

Attorney

Sara Citrowske

Filing Date

Dec 12, 2016

Add to watchlist:

No watchlists yet
View on USPTO

EKOS PE ACCEL Trademark

Serial Number: 87265335

EKOS PE ACCEL is a trademark filed by EKOS CORPORATION on December 12, 2016. The trademark is classified under Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently no longer active.

Owner Contact Info

EKOS CORPORATION (18 trademarks)

234 ALVERSON BLVD.
EVERETT, WA 982011004

Entity Type: 03

Trademark Details

Filing Date

December 12, 2016

Registration Date

Not Registered

Published for Opposition

December 12, 2017

Goods & Services

Education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; training in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; providing computer, electronic and on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; advisory services in the fields of medical education; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; electronic on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine

Surgical apparatus and instruments; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; Drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; Drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the circulatory system; Medical apparatus and instruments for use in the prevention and treatment of the circulatory system issues and conditions, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; medical devices which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; catheters; parts and fittings for all the aforesaid goods

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 15, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 15, 2021 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 30, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 30, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2020 EXRA
SOU EXTENSION 5 GRANTED
Aug 11, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 11, 2020 AITU
SOU EXTENSION 5 FILED
Jul 23, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 23, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2020 EXRA
SOU EXTENSION 4 GRANTED
Feb 6, 2020 EX4G
SOU EXTENSION 4 FILED
Feb 6, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 6, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2019 EXRA
SOU EXTENSION 3 GRANTED
Jul 29, 2019 EX3G
SOU EXTENSION 3 FILED
Jul 29, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 29, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2018 EXRA
SOU EXTENSION 2 GRANTED
Oct 23, 2018 EX2G
SOU EXTENSION 2 FILED
Oct 23, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 3, 2018 EXRA
SOU EXTENSION 1 GRANTED
Aug 1, 2018 EX1G
SOU EXTENSION 1 FILED
Aug 1, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 1, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 6, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 12, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 9, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 9, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 9, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 9, 2017 CNEA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 6, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 6, 2017 GNSL
SUSPENSION LETTER WRITTEN
Oct 6, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 15, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 15, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 15, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2017 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 1, 2017 AMPX
ASSIGNED TO LIE
Jan 31, 2017 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 12, 2017 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2016 NWOS
NEW APPLICATION ENTERED
Dec 15, 2016 NWAP